
NICE Ltd (NICE) Stock Forecast & Price Target
NICE Ltd (NICE) Analyst Ratings
Bulls say
NICE is favorably positioned because its CXone platform and Cognigy integration strengthen its leadership in CCaaS by combining omnichannel routing, workforce tools, and AI-driven handoffs that can increase interaction volume rather than merely replace human seats, while its financial crime and compliance franchise adds a profitable, diversified second engine. The company is also showing tangible AI traction, with AI ARR at $362M, up 52% Y/Y and equal to 15% of cloud revenue, cloud backlog up 19% Y/Y, AI backlog up 72% Y/Y, and a nine-figure HMRC win plus an eight-figure ACV deal with Accenture validating competitive momentum and partner-led demand. Despite near-term pressure from proactive renewals and AI investment, NICE still guided 2026 revenue to $3,170M-$3,190M, raised EPS guidance to $11.06-$11.26, expects operating margins of 25%-26%, and trades at 1.4x CY27 EV/Sales and 8.2x CY27 EV/FCF, a valuation that appears to understate the potential of its AI and cloud expansion.
Bears say
NICE is facing a mixed but increasingly fragile fundamental setup because its core cloud business is only growing 12.6% Y/Y to $609M, cloud net revenue retention has slipped to 106% from 107%, and management itself said cloud growth is merely “in line with expectations” while the company still depends on back-half acceleration to justify its 13%-15% cloud growth outlook. The quality of that growth is also uneven: total revenue rose 8% Y/Y to $782M largely on non-cloud outperformance and stronger term renewals, while services revenue fell 11% Y/Y to $125M as legacy on-premise customers migrate away, underscoring that the installed base is shrinking even as the business leans on AI-driven platform upgrades and large replacement cycles that can be lumpy. Although free cash flow was $93.1M at an 11.8% margin and the balance sheet holds $354.7M in net cash, the negative outlook reflects execution risk around AI adoption, regulatory uncertainty, and the burden of proving that the company can sustain the implied FY28 revenue expansion to $3.5B and FY26 margin targets without a stronger acceleration in core recurring growth.
This aggregate rating is based on analysts' research of NICE Ltd and is not a guaranteed prediction by Public.com or investment advice.
NICE Ltd (NICE) Analyst Forecast & Price Prediction
Start investing in NICE Ltd (NICE)
Order type
Buy in
Order amount
Est. shares
0 shares